Literature DB >> 6406538

Age-related prevalence of complement-fixing antibody to Mycoplasma pneumoniae during an 8-year period.

A Pönkä, P Ukkonen.   

Abstract

We determined the age-related prevalence of complement-fixing antibody to Mycoplasma pneumoniae from the computerized laboratory results of our routine diagnostic department. The material consisted of about 58,000 sera from an 8-year period, 1971 to 1978. Among children less than 1 month old, the frequency of complement-fixing antibody of titers greater than or equal to 8 was low (23%), and no decrease representing loss of maternal antibody was seen thereafter. An unexpectedly early increase in the antibody prevalence up to 62% was seen by 6 months of age. The frequency of antibody was high among young children from the age of 4 months, in whom symptomatic infection due to M. pneumoniae is rare. The frequency of higher titers (greater than or equal to 32) and the geometric mean titer increased more slowly, coinciding with the known age distribution of symptomatic M. pneumoniae disease; the frequency of high titers and the geometric mean titer peaked at the age of 7 to 10 years. Two explanations for the high frequency of complement-fixing antibody to M. pneumoniae in young children are discussed. It may be due to an asymptomatic infection caused by M. pneumoniae or to a nonspecific stimulus by lipids of other organisms, plants, or tissues leading to production of antibodies crossreacting with M. pneumoniae, or it may be due to both of the above. During the study, two extensive epidemics due to M. pneumoniae occurred in Finland, but the prevalence of complement-fixing antibody bore no correlation with these peaks of occurrence.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406538      PMCID: PMC272694          DOI: 10.1128/jcm.17.4.571-575.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  The occurrence and clinical picture of serologically verified Mycoplasma pneumoniae infections with emphasis on central nervous system, cardiac and joint manifestations.

Authors:  A Pönkä
Journal:  Ann Clin Res       Date:  1979

2.  STUDIES ON EATON PPLO PNEUMONIA.

Authors:  E JANSSON; O WAGER; R STENSTROEM; E KLEMOLA; P FORSSEL
Journal:  Br Med J       Date:  1964-01-18

3.  MYCOPLASMA PNEUMONIAE INFECTIONS. CLINICAL AND EPIDEMIOLOGIC STUDIES.

Authors:  J T GRAYSTON; E R ALEXANDER; G E KENNY; E R CLARKE; J C FREMONT; W A MACCOLL
Journal:  JAMA       Date:  1965-02-01       Impact factor: 56.272

4.  Mycoplasma pneumoniae infection in hospitalized patients with acute respiratory illness.

Authors:  G Biberfeld; J Stenbeck; T Johnsson
Journal:  Acta Pathol Microbiol Scand       Date:  1968

5.  Persistence of serum antibody following Mycoplasma pneumoniae infection.

Authors:  S Nakamura; I Ebisawa; O Kitamoto; T Sato
Journal:  Am Rev Respir Dis       Date:  1970-04

6.  Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance.

Authors:  H M Foy; G E Kenny; R McMahan; A M Mansy; J T Grayston
Journal:  JAMA       Date:  1970-11-30       Impact factor: 56.272

7.  Studies on the complement fixation test with Mycoplasma pneumoniae antigen. 2. Application of the test to hospitalized pneumonia patients and to healthy blood donors.

Authors:  J Eng
Journal:  Acta Pathol Microbiol Scand       Date:  1967

8.  Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques.

Authors:  H Brunner; B Prescott; H Greenberg; W D James; R L Horswood; R M Chanock
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

9.  Immunoglobulin M antibody response against Mycoplasma pneumoniae lipid antigen in patients with acute pancreatitis.

Authors:  P O Leinikki; P Panzar; H Tykkä
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

10.  Serological diagnosis of Mycoplasma pneumoniae infection by enzyme immunoassay.

Authors:  S M Räisänen; J I Suni; P Leinikki
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

View more
  5 in total

1.  Antibody levels to Mycoplasma pneumoniae in sera collected from healthy blood donors of Wellington, New Zealand, during 1976-80.

Authors:  J Pearce; K Bettleheim; R Metcalfe
Journal:  J Hyg (Lond)       Date:  1986-04

2.  The seroepidemiology of Chlamydiae in Finland over the period 1971 to 1987.

Authors:  M Puolakkainen; P Ukkonen; P Saikku
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

3.  Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark.

Authors:  K Lind; M W Bentzon
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

4.  Distributions of antibody titers to Mycoplasma pneumoniae in Korean children in 2000-2003.

Authors:  Jinho Yu; Young Yoo; Do Kyun Kim; Hee Kang; Young Yull Koh
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

5.  Age-specific prevalence of complement-fixing antibodies to sixteen viral antigens: a computer analysis of 58,500 patients covering a period of eight years.

Authors:  P Ukkonen; T Hovi; C H von Bonsdorff; P Saikku; K Penttinen
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.